Lipocine Inc. (LPCN)
NASDAQ · Healthcare
Lipocine Inc. EPS 2012–2025
Lipocine Inc. annual/quarterly eps history and growth rate from 2012 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Lipocine Inc. eps for the quarter ending March 31, 2026 was $0.54, a 54.29% increase year-over-year.
- Lipocine Inc. annual eps for 2025 was $1.69, a 46.18% decrease from 2023.
- Lipocine Inc. annual eps for 2023 was $3.14, a 46.05% increase from 2022.
- Lipocine Inc. annual eps for 2022 was $2.15, a 21400.00% increase from 2021.
- Lipocine Inc. annual eps for 2021 was $0.01.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Lipocine Inc. EPS — FAQ
Lipocine Inc. (LPCN) eps over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Lipocine Inc.'s eps?
Lipocine Inc. (LPCN) reported eps of $-1.69 for fiscal 2025.
Where can I see LPCN's eps history?
The chart and table above show Lipocine Inc.'s eps by year and by quarter, including the growth rate.